ReviewThe oncologist2026

Limited inclusion in clinical trials and access to poly (ADP-ribose) polymerase inhibitors in racial and ethnic minority patients with cancer: a narrative review.

Ashleigh Swearingen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.